Skip to main content

Atlas Focus Report: Colonoscopy

This Atlas of Healthcare Variation report on colonoscopy examines rates of MBS-subsidised repeat colonoscopies performed within 2 years and 10 months of a previous colonoscopy and highlights variation by socioeconomic disadvantage, remoteness and trends over time. The findings from this report help identify overuse of colonoscopies and ways to improve access to colonoscopies for the most vulnerable.

Key findings

8% decrease

in national rate of colonoscopy

17% decrease

in repeat colonoscopy for the most socioeconomically disadvantaged

26% decrease

in repeat colonoscopy in remote areas

Report Summary 

Rates of MBS-subsidised repeat colonoscopy before 3 years, between 2013–14 and 2023–24:

  • fell by 8% nationally
  • fell by 26% in remote areas, compared to major cities which fell by 6%
  • fell by 17% in the most socioeconomically disadvantaged areas, compared to the least socioeconomically disadvantaged areas, which increased by 2%
  • fell most in areas with consistently low rates, increasing geographic variation* from 11-fold to 18-fold and raising concerns about lack of access in some areas and repeat colonoscopies that are not clinically necessary in others.
  • Only a small proportion of people (those at higher risk of bowel cancer) are recommended a repeat (surveillance) colonoscopy before three years, if guidelines are followed.

*Difference between the local area with the highest rate and the local area with the lowest rate

Read more
 

Dashboard 

Open the dashboard in a new window

Dashboard how to videos

Using interactive features

Using interactive features

Video

Interpreting the map

Interpreting the map

Video

Not published data

Not published data

Video

What is a colonoscopy?

A colonoscopy is a medical procedure used to examine the large intestine (colon).

Colonoscopies are used to diagnose cancer, polyps, and bowel diseases, and monitor abnormalities.

The procedure involves a health professional using a colonoscope (a long flexible tube) with a camera attached to observe the inside of the colon.

Colonoscopies and bowel cancer 

Australia has one of the highest rates of bowel cancer in the world, with bowel cancer being the fourth most common cancer diagnosed in both men in Australia in 2024.1,2 Mortality rates for bowel cancer in Australia are higher outside of major cities and in socioeconomically disadvantaged areas.3 

First Nations people are also at higher risk of bowel cancer, with further research needed on the diagnosis and management of bowel cancer in First Nations people including any barriers to screening and follow up.

In Australia, most screening for bowel cancer involves an immunochemical faecal occult blood test (iFOBT) through the National Bowel Cancer Screening Program (NBCSP).

A colonoscopy is a primary method in: 

  • Diagnosing and confirming bowel cancer after iFOBT screening; and
  • Monitoring (surveillance) of abnormalities for people at increased risk of bowel cancer or who have chronic conditions 

If surveillance is required, a person may need a repeat colonoscopy at 1, 3, 5 or 10 years with 5 years often recommended. 

If guidelines are followed4, only a small proportion of people require a repeat colonoscopy before 3 years. They are usually people with specific risk factors identified at their initial colonoscopy that require a repeat procedure within a shorter interval, and it is important that the repeat procedure is performed without undue delay. 
 

Clinical commentary 

Common reasons for needing another colonoscopy after a previous one include:

  • Poor bowel preparation or an incomplete procedure
  • Pre-operative planning or assessment
  • Surveillance of the bowel after removal of pre-cancerous polyp(s) that can lead to bowel cancer
  • Surveillance of the bowel after an initial diagnosis and management of bowel cancer
  • Surveillance of chronic conditions of the bowel such as inflammatory bowel disease, that may increase the risk of bowel cancer
  • Surveillance of people with a strong family history of bowel cancer, or a hereditary cancer syndrome that can lead to bowel cancer
  • Investigation of new signs or symptoms related to the bowel, such as rectal bleeding, change in bowel habit and weight loss.

If current national guidelines are followed4, only a small proportion of people would be expected to need a repeat colonoscopy before 3 years. These are usually people with specific risk factors identified at their initial colonoscopy that require a repeat procedure within a shorter interval, and it is important that the repeat procedure is performed without undue delay. 

Substantial variation in repeat colonoscopy data for 2018–19 was reported in the Fourth Australian Atlas of Healthcare Variation: rates were substantially higher in major cities than in other areas and decreased with socioeconomic disadvantage.5 This is the reverse of the pattern of mortality rates, which are lower in major cities and higher in socioeconomically disadvantaged populations.6 Waiting time between a positive screening test and colonoscopy is also longer outside major cities and in the most disadvantaged areas.6

Overuse of colonoscopy in low-risk patients in some areas may be diverting resources away from where they are needed most, and contribute to reduced access to colonoscopy for people in rural, remote and socioeconomically disadvantaged areas.7 Overuse in low-risk patients also exposes them to unnecessary risks associated with complications of colonoscopy, such as perforation or complications from bowel preparation or anaesthesia.8

Changes to MBS items

In 2019, MBS items for colonoscopy services were changed in response to the Gastroenterological Clinical Committee of the MBS Review Taskforce’s concerns about inequity of access and high volumes of unnecessary colonoscopies for low-risk patients. The MBS items for surveillance colonoscopy were aligned with the surveillance intervals recommended in national guidelines.9, 10

This report examines the number of MBS-subsidised colonoscopies performed within 2 years and 10 months of a previous colonoscopy, per 100,000 people between 2013–14 and 2023–24 (repeat colonoscopy). The interval was chosen to exclude services to people who presented slightly early for a 3-year surveillance colonoscopy.

The report presents trend data and visualisations for:

  • Australia and its states and territories
  • Remoteness and socioeconomic status levels
  • Primary Health Networks (PHNs)
  • Local areas (SA3s).
National trends 
  • Rates of MBS-subsidised repeat colonoscopy before 2 years and 10 months fell nationally by 8% between 2013–14 and 2023–24.
  • Greater decreases were seen in remote areas compared to major cities, and in areas of most socioeconomic disadvantage compared to least socioeconomic disadvantage.
  • In 2013–14, there were 126,992 MBS-subsidised repeat colonoscopy services (500 per 100,000 people) compared to 141,558 services in 2023–24 (460 per 100,000 people).
  • In 2013–14, there was an 11-fold difference between the local area with the highest rate of MBS-subsidised repeat colonoscopy and the local area with the lowest rate, compared to 2023–24, when there was an 18-fold difference.
State and territory trends
  • South Australia, Western Australia and the Northern Territory were the only states to record an increase in the rate of MBS-subsidised repeat colonoscopies between 2013–14 and 2023–24.
  • The largest decrease was 14% in New South Wales and the largest increase was 13% in South Australia.
Remoteness
  • Remote areas fell by 26% (157 to 116 per 100,000 people), compared to major cities which fell by 6% (543 to 510 per 100,000 people), between 2013–14 and 2023–24.
  • The difference in MBS-subsidised repeat colonoscopy rates between major cities and remote areas increased from 3.5-fold in 2013–14 to 4.4-fold in 2023–24.
Socioeconomic status
  • The most socioeconomically disadvantaged areas consistently had the lowest rate (334 per 100,000 people) of MBS-subsidised repeat colonoscopy, and the least socioeconomically disadvantaged areas consistently had the highest rate (609 per 100,000 people).
  • The most socioeconomically disadvantaged areas fell by 17%, compared to the least socioeconomically disadvantaged areas, which increased by 2%.
  • The difference in MBS-subsidised repeat colonoscopy rates between the most disadvantaged areas and the least disadvantaged areas increased from 1.5-fold in 2013–14 to 1.8-fold in 2023–24.
Primary Health Networks (PHNs)
  • The largest decrease in repeat colonoscopy rates between 2013–14 and 2023–24 was 43% in Northern Queensland PHN, and the largest increase was 37% in Brisbane North PHN.

Possible reasons for variation in rates of MBS-subsidised repeat colonoscopy include:

Consumer factors

  • Ability to pay out of pocket costs and to take time off work
  • Ability to afford private health insurance and variation in level of cover for colonoscopy items
  • Language and cultural barriers11, 12
  • Comorbidities and other competing demands12
  • Expectation of colonoscopy and desire for peace of mind, which may drive up rates in some areas13
  • Awareness of bowel cancer symptoms and the NBCSP, and participation in screening.

Clinician factors

  • Performing surveillance colonoscopy earlier than recommended 14-16, which may be influenced by fear of missing pathology, the fee for service model, malpractice concerns and patient and referrer expectations13, 15, 16
  • Lack of awareness, and complexity, of current guidelines15, 17
  • Difficulty sharing reports or accessing previous reports.7

System factors

  • Differences in the proportion of services subsidised by the MBS in each state and territory, which also varied over time
  • Fee for service model13, 15
  • Limited endoscopist workforce and infrastructure in some regional and remote areas18
  • Limited access to General Practitioners in some areas, reducing referrals19
  • Waiting time for outpatient appointments
  • Lack of information management and communication systems for both recall and follow-up
  • Lack of access to previous patient reports and multiple platforms for reporting in use
  • Logistical barriers to screening in some areas, such as environmental heat effect on samples, and postal access20
  • Limited governance over private colonoscopy
  • State/territory programs to address access to colonoscopy.

Potential strategies to support appropriate use of repeat colonoscopy and increase equity of access include:

Consumers

  • Participate in the National Bowel Cancer Screening Program at recommended intervals
  • If your doctor recommends a colonoscopy, ask questions so you understand the reason, the risks and the benefits for you21
  • Ask your colonoscopist to upload your colonoscopy report to My Health Record
  • Reduce your risk factors for bowel cancer with lifestyle changes.

General Practitioners

Colonoscopists

  • Provide high-quality colonoscopy aligned with the Colonoscopy Clinical Care Standard
  • Align intervals for surveillance colonoscopy with the Cancer Council Australia’s Clinical practice guidelines for surveillance colonoscopy
  • Critically evaluate and audit your own practice on a regular basis to ensure consistency with evidence-based guidelines for surveillance colonoscopy
  • Ensure patient consent includes an understanding of the benefits and potential complications of colonoscopy and of evidence-based guidelines on colonoscopy surveillance intervals22
  • Communicate the reason for the colonoscopy, its findings, all histology results and recommendations for follow-up in writing to the GP, all other relevant clinicians and the patient21
  • Provide reports to be recorded in the facility records, and upload to My Health Record, to enable accurate follow-up by other clinicians21
  • Locate previous colonoscopy reports, from facility records or other shared record management system, before assessing for a repeat colonoscopy.

Clinical societies and colleges

  • Support trainee gastroenterologist positions in underserved areas, with flexible training models if necessary
  • Support training in colonoscopy for rural generalists, general practitioners and nurses7
  • Provide training for clinicians about correct surveillance intervals7
  • Promote exchange programs for regional/remote endoscopists with metropolitan colleagues to support the rural workforce
  • Develop decision support tools to support selection of appropriate surveillance intervals7
  • Develop decision support tools to explain the absolute risk of bowel cancer at different ages to patients.7

Policy makers

  • Explore funding models that recognise the complexity and cost of providing colonoscopy services in regional and remote areas
  • Provide culturally safe services
  • Provide targeted education about screening for Aboriginal and Torres Strait Islander people, and consumers in underserved areas, in appropriate languages7, 11
  • Increase access to Aboriginal Community Controlled Health Organisations
  • Mandate and support uploading of colonoscopy reports and histology results to My Health Record through the share by default program7
  • Require justification of repeat colonoscopy intervals that do not align with guidelines to qualify for payments
  • Require private health insurers to provide data about procedures to inform research on quality use of colonoscopy
  • Map the need for colonoscopy against capacity, redistribute triaged waiting lists and support outreach programs for underserved areas.7

Hospitals, endoscopy clinics and private practices

  • Review implementation of the Colonoscopy Clinical Care Standard, and associated policies and procedures, and monitor progress in indicators – see the Self-Assessment Tool
  • Provide regular and repeated education to clinicians about appropriate surveillance intervals7
  • Conduct audits of repeat colonoscopy to ensure follow-up intervals align with evidence-based guidelines
  • Ensure systems are in place to allow access to previous colonoscopy and pathology results
  • Consider employing a colonoscopy liaison nurse if volumes of colonoscopy are high.

Colonoscopy Topic Expert Group

The Atlas Focus Report: Colonoscopy was developed in consultation with a topic expert group that provided clinical advice for the report. Members of the group included: 

Dr Phoebe Holdenson Kimura (Chair)General Practitioner; Medical Advisor, Australian Commission on Safety and Quality in Health Care, NSW
Dr Jason AgostinoGeneral Practitioner; Senior Medical Advisor, National Aboriginal Community Controlled Health Organisation (NACCHO), ACT
Dr Karen Louise BarclayGeneral and Colorectal Surgeon, VIC 
Dr Lauren BeswickDirector of Gastroenterology, Barwon Health, VIC
Dr Sneha JohnFRACP Director of Endoscopy, Gold Coast University Hospital, QLD
Dr Kirsty CampbellClinical Lead of Gastroenterology, Royal Darwin Hospital, NT

Success Story

Strengthening foundations for auditing and oversight in colonoscopy care

Strengthening foundations for auditing and oversight in colonoscopy care

Case study from Northern NSW Local Health District.

About the data

  1. Morgan E, Arnold M, Gini A, et al. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 2023 Feb;72(2):338-344.
  2. Australian Institute of Health and Welfare. Cancer data in Australia, 2024 [Internet]. AIHW; 2024. https://www.aihw.gov.au/reports/cancer/cancer-data-in-australia/contents/overview (accessed 1 July 2025).
  3. Australian Institute of Health and Welfare. National bowel cancer screening monitoring report. Supplementary tables S3.19b and S3.21b. Canberra: AIHW, 2025. https://www.aihw.gov.au/reports/cancer-screening/nbcsp-monitoring-2025/data (accessed 1 July 2025).
  4. Cancer Council Australia. Clinical practice guidelines for surveillance colonoscopy. https://www.cancer.org.au/clinical-guidelines/bowel-cancer/surveillance-colonoscopy (accessed 1 July 2025).
  5. Australian Commission on Safety and Quality in Health Care. The Fourth Atlas of Healthcare Variation. Sydney: ACSQHC; 2021. /node/101 (accessed 1 July 2025).
  6. Australian Institute of Health and Welfare. National bowel cancer screening monitoring report. Canberra: AIHW, 2025. https://www.aihw.gov.au/reports/cancer-screening/nbcsp-monitoring-2025/data (accessed 1 July 2025).
  7. MBS Review Advisory Committee. Colonoscopy post-implementation review - final report. Canberra: Australian Government, Department of Health and Aged Care, 2024. https://www.health.gov.au/resources/publications/mrac-colonoscopy-post-implementation-review-final-report?language=en (accessed 10 June 2025).
  8. Lv XH, Lu Q, Wang ZJ, et al. Colonoscopy-Related Adverse Events in the 21st Century: An Updated Systematic Review and Meta-Analysis. Am J Gastroenterol. 2025 Mar 27.
  9. MBS Online. Medicare Benefits Schedule Fact Sheet: Changes to colonoscopy services. Canberra: Australian Government, Department of Health, 2018. https://www.mbsonline.gov.au/internet/mbsonline/publishing.nsf/Content/CF0EAA5B9C7416A4CA25814600209324/$File/Updated%20Colonoscopy%20Services%202%20Feb%202018.pdf (accessed 10 June 2025).
  10. Cancer Council Australia. Clinical practice guidelines for the prevention, early detection and management of colorectal cancer. Cancer Council Australia, https://www.cancer.org.au/clinical-guidelines/bowel-cancer/colorectal-cancer (accessed 1 July 2025).
  11. D'Onise K, Iacobini ET, Canuto KJ. Colorectal cancer screening using faecal occult blood tests for Indigenous adults: A systematic literature review of barriers, enablers and implemented strategies. Prev Med. 2020 May;134:106018.
  12. Shahid S, Lau B, Holub J, O'Neil N. Support along the cancer pathway for Aboriginal and Torres Strait Islander peoples: An Evidence Check rapid review brokered by the Sax Institute. Sydney: Cancer Institute NSW, 2021.
  13. Emanuel EJ, Fuchs VR. The perfect storm of overutilization. JAMA. 2008 Jun 18;299(23):2789-2791.
  14. Bunjo Z, Koh YH, Leopardi L, et al. Surveillance colonoscopies frequently booked earlier than the National Health and Medical Research Council guidelines: findings of a single centre audit. ANZ J Surg. 2019 Mar;89(3):E61-E65.
  15. Djinbachian R, Dube AJ, Durand M, et al. Adherence to post-polypectomy surveillance guidelines: a systematic review and meta-analysis. Endoscopy. 2019 Jul;51(7):673-683.
  16. Ho YM, Merollini KMD, Gordon LG. Frequency of colorectal surveillance colonoscopies for adenomatous polyps: systematic review and meta-analysis. J Gastroenterol Hepatol. 2024 Jan;39(1):37-46.
  17. Fitzsimmons T, Jayasena W, Holden CA, et al. Assessing the impact of the 2018 National Health and Medical Research Council polyp surveillance guidelines on compliance with surveillance intervals at two public hospitals. ANZ J Surg. 2022 Nov;92(11):2942-2948.
  18. Choi MS, van der Mark MA, Hung K. The Distribution and Composition of Colonoscopy Providers in Australia. Cureus. 2022 Feb;14(2):e22104.
  19. Australian Institute of Health and Welfare. Modelling access to GPs relative to need in Australia: Geographic variation among First Nations and non-Indigenous populations, catalogue number IHW 293, AIHW, Australian Government. https://www.aihw.gov.au/reports/indigenous-australians/modelling-access-gps-geographic-variation/summary (accessed 1 July 2025). 2024.
  20. Dasgupta P, Cameron JK, Goodwin B, et al. Geographical and spatial variations in bowel cancer screening participation, Australia, 2015-2020. PLoS One. 2023;18(7):e0288992.
  21. Australian Commission on Safety and Quality in Health Care. Colonoscopy Clinical Care Standard. Sydney: ACSQHC, 2025.
  22. Safer Care Victoria. Promoting best practice colonoscopy. Melbourne: Victorian Government, 2025. Available from https://www.safercare.vic.gov.au/sites/default/files/2024-10/Promoting%20best%20practice%20colonoscopy%20recommendations%20report.pdf.
  23. Royal Australian College of General Practitioners. Guidelines for preventive activities in general practice (the Red Book). East Melbourne: RACGP, 2024. https://www.racgp.org.au/clinical-resources/clinical-guidelines/key-racgp-guidelines/view-all-racgp-guidelines/preventive-activities-in-general-practice/about-the-red-book?utm_source=Home+page+tile&ut (accessed 1 July 2025).

Last updated: 13 March 2026